Inspire Medical Systems I... (INSP)
Inspire Medical Systems Statistics
Share Statistics
Inspire Medical Systems has 29.76M shares outstanding. The number of shares has increased by 0.16% in one year.
| Shares Outstanding | 29.76M |
| Shares Change (YoY) | 0.16% |
| Shares Change (QoQ) | -0.69% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 28.31M |
| Failed to Deliver (FTD) Shares | 456 |
| FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 2.28M, so 7.62% of the outstanding shares have been sold short.
| Short Interest | 2.28M |
| Short % of Shares Out | 7.62% |
| Short % of Float | 7.75% |
| Short Ratio (days to cover) | 3.57 |
Valuation Ratios
The PE ratio is 103.11 and the forward PE ratio is 99.24. Inspire Medical Systems's PEG ratio is -0.29.
| PE Ratio | 103.11 |
| Forward PE | 99.24 |
| PS Ratio | 6.87 |
| Forward PS | 2.8 |
| PB Ratio | 8 |
| P/FCF Ratio | 60.55 |
| PEG Ratio | -0.29 |
Enterprise Valuation
Inspire Medical Systems has an Enterprise Value (EV) of 5.4B.
| EV / Sales | 6.72 |
| EV / EBITDA | 83.01 |
| EV / EBIT | 41.44 |
| EV / FCF | 59.23 |
Financial Position
The company has a current ratio of 7.13, with a Debt / Equity ratio of 0.04.
| Current Ratio | 7.13 |
| Quick Ratio | 6.22 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.46 |
| Debt / FCF | 0.33 |
| Interest Coverage | 1640.14 |
Financial Efficiency
Return on Equity is 7.76% and Return on Invested Capital is 4.59%.
| Return on Equity | 7.76% |
| Return on Assets | 6.62% |
| Return on Invested Capital | 4.59% |
| Revenue Per Employee | $644.3K |
| Profits Per Employee | $42.94K |
| Employee Count | 1,246 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 1.54 |
Taxes
| Income Tax | 4.94M |
| Effective Tax Rate | 8.46% |
Stock Price Statistics
The stock price has increased by -23.92% in the last 52 weeks. The beta is 1.48, so Inspire Medical Systems's price volatility has been higher than the market average.
| Beta | 1.48 |
| 52-Week Price Change | -23.92% |
| 50-Day Moving Average | 177.78 |
| 200-Day Moving Average | 181.09 |
| Relative Strength Index (RSI) | 40.24 |
| Average Volume (20 Days) | 548.92K |
Income Statement
In the last 12 months, Inspire Medical Systems had revenue of 802.8M and earned 53.51M in profits. Earnings per share was 1.8.
| Revenue | 802.8M |
| Gross Profit | 679.82M |
| Operating Income | 36.08M |
| Net Income | 53.51M |
| EBITDA | 65.03M |
| EBIT | 58.48M |
| Earnings Per Share (EPS) | 1.8 |
Balance Sheet
The company has 150.15M in cash and 30.04M in debt, giving a net cash position of 120.11M.
| Cash & Cash Equivalents | 150.15M |
| Total Debt | 30.04M |
| Net Cash | 120.11M |
| Retained Earnings | -291.91M |
| Total Assets | 808.38M |
| Working Capital | 542.3M |
Cash Flow
In the last 12 months, operating cash flow was 130.25M and capital expenditures -39.12M, giving a free cash flow of 91.12M.
| Operating Cash Flow | 130.25M |
| Capital Expenditures | -39.12M |
| Free Cash Flow | 91.12M |
| FCF Per Share | 3.06 |
Margins
Gross margin is 84.68%, with operating and profit margins of 4.49% and 6.67%.
| Gross Margin | 84.68% |
| Operating Margin | 4.49% |
| Pretax Margin | 7.28% |
| Profit Margin | 6.67% |
| EBITDA Margin | 8.1% |
| EBIT Margin | 4.49% |
| FCF Margin | 11.35% |
Dividends & Yields
INSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 0.97% |
| FCF Yield | 1.65% |
Analyst Forecast
The average price target for INSP is $233.5, which is 46% higher than the current price. The consensus rating is "Buy".
| Price Target | $233.5 |
| Price Target Difference | 46% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
Scores
| Altman Z-Score | 25.3 |
| Piotroski F-Score | 5 |